Randomized Trial Of Adjuvant Nab-Paclitaxel Plus Gemcitabine (Nab-P/G) Vs Gemcitabine (G) For Surgically Resected Pancreatic Adenocarcinoma.

PANCREAS（2019）

引用 126|浏览55

暂无评分

摘要

4000Background: In metastatic pancreatic cancer (PC), nab-P/G demonstrated significantly longer overall survival (OS) vs G. APACT assessed efficacy & safety of nab-P/G vs G in surgically resected P...

查看译文

关键词

pancreatic adenocarcinoma,adjuvant,gemcitabine,open-label

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要